AMERICAN SHARED HOSPITAL SERVICES Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-31
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 0.00 shares.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 0.00 shares.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was 20.00K shares.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-03-31 was 50.00K shares.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 70.00K shares, a 40.00% increase from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 50.00K shares, a 733.33% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-31 | |||
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-31 | |||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | 0.00 shares derived: sum of 2 quarters · filed 2025-04-04 | 20.00K shares derived: sum of 3 quarters · filed 2025-04-04 | 70.00K shares 10-K · filed 2025-04-04 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 20.00K shares derived: sum of 2 quarters · filed 2024-11-14 | 70.00K shares 10-Q · filed 2024-11-14 | 70.00K shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 20.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 70.00K shares 10-Q · filed 2024-08-14 | 70.00K shares derived: sum of 3 quarters · filed 2024-08-14 | |
| 2023-03-31 | 50.00K shares 10-Q · filed 2024-05-15 | 50.00K shares derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 50.00K shares 10-K · filed 2024-04-01 | ||
| 2022-09-30 | 50.00K shares 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-31 | 6.00K shares 10-K · filed 2023-03-31 | |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 6.00K shares 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | 6.00K shares 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-30 | 10.00K shares 10-K · filed 2022-03-30 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 10.00K shares 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | 10.00K shares 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-06 | 0.00 shares derived: sum of 2 quarters · filed 2021-04-06 | 18.00K shares 10-K · filed 2021-04-06 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | 18.00K shares 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | 18.00K shares 10-Q · filed 2020-08-14 | |||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | 0.00 shares derived: sum of 2 quarters · filed 2020-04-03 | 16.00K shares 10-K · filed 2020-04-03 | |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 16.00K shares 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | 16.00K shares 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | 27.00K shares 10-K · filed 2019-03-29 | |||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | 0.00 shares derived: sum of 2 quarters · filed 2017-03-27 | 17.00K shares derived: sum of 3 quarters · filed 2017-03-27 | 20.00K shares 10-K · filed 2017-03-27 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 17.00K shares derived: sum of 2 quarters · filed 2016-11-10 | 20.00K shares 10-Q · filed 2016-11-10 | 20.00K shares derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | 17.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 20.00K shares 10-Q · filed 2016-08-11 | 20.00K shares derived: sum of 3 quarters · filed 2016-08-11 | 28.00K shares derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | 3.00K shares 10-Q · filed 2016-05-12 | 3.00K shares derived: sum of 2 quarters · filed 2016-05-12 | 11.00K shares derived: sum of 3 quarters · filed 2016-05-12 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 8.00K shares derived: sum of 2 quarters · filed 2016-03-30 | 20.00K shares 10-K · filed 2016-03-30 | |
| 2015-09-30 | 8.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 20.00K shares 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | 12.00K shares 10-Q · filed 2015-08-19 | |||
| 2014-12-31 | -33.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-01 | -33.00K shares derived: sum of 2 quarters · filed 2015-04-01 | -29.00K shares derived: sum of 3 quarters · filed 2015-04-01 | 522.00K shares 10-K · filed 2015-04-01 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | 4.00K shares derived: sum of 2 quarters · filed 2014-11-14 | 555.00K shares 10-Q · filed 2014-11-14 | |
| 2014-06-30 | 4.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-15 | 555.00K shares 10-Q · filed 2014-08-15 | ||
| 2014-03-31 | 551.00K shares 10-Q · filed 2014-05-15 | |||
| 2013-12-31 | 21.50K shares 10-K · filed 2014-03-31 | |||
| 2012-12-31 | 21.00K shares 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |